AI주식인사이트AI Stock Insight
B

이글벳

044960KOSDAQ

61.5 / 100

Reference Date: 2026-09-08

Financial Score29.0 / 40
News Sentiment12.5 / 25
Momentum10.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Revenue metrics are weak. Slightly up 3.2% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Eglvet is a company specializing in the manufacturing and import of animal pharmaceuticals, leveraging the growth of the livestock industry both domestically and internationally. Its key products include nutritional supplements, antibiotics, and vaccines, with active expansion into overseas markets such as Africa, the Middle East, and Southeast Asia. The company is also exploring research opportunities in the growing pet pharmaceutical market.

Number of Employees

110people

Average Salary

48.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
10.17Industry Average 15.006.5Point

Lower than industry avg (good)

PBR
0.77Industry Average 1.205.5Point

Lower than industry avg (good)

ROE
7.85Industry Average 8.002.5Point

Below industry avg

Debt Ratio
6.70Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲0.7% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲13.6% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 7.5% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (23%)

Current 3,175Won52-week high 4,50052-week low 2,765
1-month return4.0Point

1m +3.25% (slight rise)

Volume trend3.0Point

Volume flat

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral반기보고서 (2026.06)2026-08-14